Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Interactive Chart for Viking Therapeutics, Inc. (VKTX), analyze all the data with a huge range of indicators.

Get the latest Viking Therapeutics, Inc. (VKTX) stock news and headlines to help you in your trading and investing decisions.

Oct 24, 2024 · Viking Therapeutics Inc (NASDAQ:VKTX) reported a net loss of $24.9 million for the third quarter of 2024, an increase from the previous year.

Feb 27, 2024 · Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and …

Discover historical prices for VKTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Viking Therapeutics, Inc. stock was issued.

Oct 9, 2024 · (NASDAQ:VKTX) released data from the Phase 1b trial of VK0214, a novel small molecule agonist of the thyroid hormone receptor beta (TRβ), in patients with X-linked …

Oct 24, 2024 · Viking Therapeutics VKTX reported third-quarter 2024 loss per share of 22 cents, narrower than the Zacks Consensus Estimate of a loss of 24 cents. The company had incurred …

Jan 2, 2025 · Shares of Viking Therapeutics VKTX have lost nearly 22% in the past six months, significantly underperforming the industry’s 5.3% decline. The stock also underperformed the …

Nov 21, 2024 · In this article, we are going to take a look at where Viking Therapeutics Inc. (NASDAQ:VKTX) stands against the other Redditor-approved stocks.